Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials.

Mushtaq, Adeela

Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. [electronic resource] - Clinical lymphoma, myeloma & leukemia 07 2019 - 447-461 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

2152-2669

10.1016/j.clml.2019.04.003 doi


Antineoplastic Combined Chemotherapy Protocols--adverse effects
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
Humans
Multiple Myeloma--drug therapy
Recurrence
Retreatment
Thalidomide--administration & dosage
Treatment Outcome